Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TCI Gene Inc. (6879:TWSE), powered by AI.
TCI Gene Inc. is currently trading at $37.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for TCI Gene Inc. on Alpha Lenz.
View TCI Gene Inc.'s valuation metrics on Alpha Lenz.
“TCI Gene Inc.'s ROE is 4.3%. Explore profitability and growth together.”
Ask for details →TCI Gene Inc. is a biotechnology company specializing in the development and manufacturing of gene testing, stem cell, and immune cell products. Its core services include precision genetic testing for health-related traits such as nutrient metabolism and weight management, virus detection, and cell-based experiments. The company also offers stem cell therapies, natural killer cell production, and personalized healthcare products, including nutrition supplements and gene-targeted health foods. Additionally, TCI Gene Inc. provides skincare, antiaging solutions, and specialized products for children’s growth and neurodegenerative disease support. By combining advanced R&D capabilities with customized health management solutions, TCI Gene Inc. plays a vital role in supporting preventive medicine and personal wellness within the healthcare sector. Established in 2011 and based in Taipei, it contributes to the integration of biotechnology with individualized healthcare, reinforcing the growing significance of precision medicine in regional and global markets.
“TCI Gene Inc.'s ROE is 4.3%. Explore profitability and growth together.”
Ask for details →TCI Gene Inc. (ticker: 6879) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 37 with a P/E ratio of -x and P/B of -x.
ROE is 4.35% and operating margin is 6.97%. Annual revenue is $274M.